National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma.
about
The use of adjuvant chemotherapy for pancreatic cancer varies widely between hospitals: a nationwide population-based analysis.Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.The role of multidisciplinary meetings for benign pancreatobiliary diseases: a tertiary centre experience.
P2860
National compliance to an evidence-based multidisciplinary guideline on pancreatic and periampullary carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
National compliance to an evid ...... c and periampullary carcinoma.
@en
type
label
National compliance to an evid ...... c and periampullary carcinoma.
@en
prefLabel
National compliance to an evid ...... c and periampullary carcinoma.
@en
P2093
P1433
P1476
National compliance to an evid ...... c and periampullary carcinoma.
@en
P2093
Ate van der Gaast
Fibo J W Ten Kate
Laetitia Veerbeek
Lennart B van Rijssen
Lydia G M van der Geest
Marco J Bruno
Olivier R C Busch
Thomas L Bollen
P304
P356
10.1016/J.PAN.2015.10.002
P577
2015-10-26T00:00:00Z